Characterizing pediatric emergency department visits during the COVID-19 pandemic

Jesse M Pines1, Mark S Zocchi2, Bernard S Black3

  • 1US Acute Care Solutions, Canton, OH, United States of America; Department of Emergency Medicine, Allegheny Health Network, Pittsburgh, PA, United States of America.

Insights

Pediatric emergency department (ED) visits decreased significantly more than adult visits during the COVID-19 pandemic. This trend persisted, particularly for younger children, and affected serious conditions, indicating potential avoidance of necessary care.

Area of Science:

  • Public Health
  • Pediatrics
  • Epidemiology

Background:

  • The COVID-19 pandemic significantly impacted healthcare utilization across various medical settings.
  • Understanding changes in pediatric emergency department (ED) visits is crucial for assessing the pandemic's broader health effects on children.

Purpose of the Study:

  • To quantify the changes in pediatric emergency department (ED) visits during the COVID-19 pandemic.
  • To compare pediatric ED visit trends with adult ED visit trends.
  • To analyze pediatric ED visit patterns by age, disposition, and diagnosis during the pandemic.

Main Methods:

  • Retrospective analysis of non-COVID-19 emergency department (ED) visits from January to June 2020.
  • Comparison of weekly visit data with the corresponding period in 2019.
  • Calculation of 2020-2019 visit ratios for adults and children (≤18 years) by age group.

Main Results:

  • Pediatric ED visits declined more sharply than adult visits, with peak declines of 74% for children <10 years and 67% for 14-17 year olds.
  • By June 2020, pediatric visits recovered to 72% of 2019 levels for older children but only 50% for younger children (<10 years).
  • Significant declines were observed across all diagnoses, including a 22% decrease in common serious pediatric conditions like appendicitis.

Conclusions:

  • Pediatric emergency department (ED) visits experienced a more pronounced decline compared to adult visits during the COVID-19 pandemic.
  • The persistent decrease in visits, especially for younger children and for serious conditions, suggests a potential parental hesitancy to seek necessary medical care.
  • These findings highlight the need for targeted public health messaging to ensure children receive timely medical attention.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
112
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
112
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
138
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
111
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
129
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
210